Cipla Ltd

CIPLA NSE Healthcare Pharmaceuticals
Nifty 50 Nifty 100 Nifty 200 Nifty 500 LargeMid 250 F&O
₹1,366.00
-0.53%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.02.
  • Comfortable interest cover: operating profit covers interest about 108.9 times.
  • Return on equity is moderate at 11.6%.
  • Return on capital employed is healthy at 15.5%.
  • Net profit margin is 13.7%.
  • Pays a dividend (yield about 0.94%).
  • Has paid a dividend in each of the last 5 years on record.

!Watch-points

  • Recent profit growth (-34%) is slower than the five-year pace (10%).
  • Promoter holding is relatively low (29.22%).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreSafe zone
3.84

In Altman’s original study, companies in this range showed a low incidence of financial distress.

Computed without the working-capital term (current-asset split not available for this stock).

Piotroski F-ScoreWeak
3 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 1.10L Cr
Current Price₹ 1,366.00
High / Low₹ 1,673.00 / 1,165.70
Stock P/E32.718563
Book Value₹ 426.00
Dividend Yield0%
ROCE15.50%
ROE11.60%
Face Value₹ 2.00
Debt to Equity0.02
PEG Ratio3.13
EV / EBITDA15.86
Industry PE35.25
P/B Ratio3.2046697
EPS₹ 48.02
Debt₹ 614 Cr
PAT Margin13.71%
Cash PAT₹ 5,073 Cr
ICR108.94
Promoter Holding29.22%
FII Holding20.20%
DII Holding34.35%
Public Holding15.93%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Compounded Sales Growth
10 Years 7.00%
5 Years 8.00%
3 Years 7.00%
TTM 2.00%
Compounded Profit Growth
10 Years 11.00%
5 Years 10.00%
3 Years 10.00%
TTM -34.00%
Stock Price CAGR
10 Years 9.00%
5 Years 8.00%
3 Years 3.00%
1 Year -11.00%
Return on Equity
10 Years 13.00%
5 Years 14.00%
3 Years 15.00%
Last Year 12.00%
Educational data only. Not a recommendation to buy, sell or hold any security.